VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ACHV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ACHVAchieve Life Sciences, Inc.
$6.23$333M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksACHVQuarterly Financials

Achieve Life Sciences, Inc. (ACHV) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Achieve Life Sciences, Inc. (ACHV) quarterly income statement — complete revenue, gross profit & net income history

ACHV Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold57K054K0000000100K000000000
COGS % of Revenue--------------------
Gross Profit-57K0-54K0000000-100K000000000
Gross Margin %--------------------
Gross Profit Growth %------100%-------------
Operating Expenses10.41M14.73M14.64M12.56M12.89M12.19M12.47M8.43M5.98M4.39M6.47M7.71M8.58M10.86M12.64M10.07M7.23M7.12M6.69M11.3M
OpEx % of Revenue--------------------
Selling, General & Admin7.11M10.86M9.37M5.86M5.8M4.89M4.86M3.32M3.18M2.27M2.89M3.13M3.04M2.25M2.77M2.87M2.84M2.61M2.1M2.08M
SG&A % of Revenue--------------------
Research & Development3.29M3.87M5.32M6.71M7.1M7.3M7.61M5.11M2.8M2.11M3.58M4.58M5.53M8.61M9.87M7.21M4.39M4.51M4.59M9.23M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-10.46M-14.73M-14.69M-12.56M-12.89M-12.19M-12.47M-8.43M-5.98M-4.39M-6.57M-7.71M-8.58M-10.86M-12.64M-10.07M-7.23M-7.12M-6.69M-11.3M
Operating Margin %--------------------
Operating Income Growth %18.85%-20.84%-17.86%-49.01%-115.55%-177.93%-89.68%-9.29%30.26%59.62%48%23.42%-18.71%-52.66%-88.84%10.87%9.49%-50.71%-78.29%-287.32%
EBITDA-10.41M-14.67M-14.64M-12.51M-12.83M-12.13M-12.41M-8.37M-5.92M-4.33M-6.47M-7.66M-8.52M-10.8M-12.58M-10.02M-7.17M-7.05M-6.63M-11.24M
EBITDA Margin %--------------------
EBITDA Growth %18.91%-20.95%-17.95%-49.37%-116.57%-180.25%-91.73%-9.34%30.46%59.91%48.57%23.54%-18.89%-53.08%-89.75%10.87%9.52%-51.45%-79.78%-293.94%
D&A (Non-Cash Add-back)57K57K55K55K62K58K57K57K57K57K100K55K58K65K55K56K60K62K61K63K
EBIT-10.46M-14.41M-14.25M-12.53M-12.64M-12.16M-12.15M-7.66M-5.68M-4.69M-6.33M-7.53M-8.42M-10.69M-12.6M-10.06M-7.22M-7.12M-6.69M-11.31M
Net Interest Income23K176K362K1K137K285K307K29K-445K-579K-519K-519K-411K-429K-408K-400K-353K3K3K3K
Interest Income297K427K554K192K322K482K673K833K368K208K262K193K162K118K73K4K4K3K3K3K
Interest Expense274K251K192K191K185K197K366K804K813K787K781K712K573K547K481K404K357K000
Other Income/Expense295K69K251K-155K67K-170K-46K-30K-512K-1.09M-536K-525K-414K-370K-438K-395K-347K-36K2K-9K
Pretax Income-10.17M-14.66M-14.44M-12.72M-12.83M-12.36M-12.51M-8.46M-6.49M-5.48M-7.11M-8.24M-8.99M-11.23M-13.08M-10.47M-7.57M-7.15M-6.69M-11.31M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-10.17M-14.66M-14.44M-12.72M-12.83M-12.36M-12.51M-8.46M-6.49M-5.48M-7.11M-8.24M-8.99M-11.23M-13.08M-10.47M-7.57M-7.15M-6.69M-11.31M
Net Margin %--------------------
Net Income Growth %20.73%-18.62%-15.42%-50.31%-97.52%-125.71%-76.03%-2.69%27.78%51.25%45.65%21.29%-18.74%-57.07%-95.44%7.45%5.33%-51.38%-77.76%-287.1%
Net Income (Continuing)-10.17M-14.66M-14.44M-12.72M-12.83M-12.36M-12.51M-8.46M-6.49M-5.48M-7.11M-8.24M-8.99M-11.23M-13.08M-10.47M-7.57M-7.15M-6.69M-11.31M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.19-0.28-0.28-0.37-0.37-0.36-0.36-0.25-0.26-0.26-0.34-0.43-0.50-0.81-1.40-1.13-0.84-0.76-0.71-1.53
EPS Growth %48.65%22.22%22.22%-48%-42.31%-38.46%-5.88%41.86%48%67.9%75.71%61.95%40.48%-6.58%-97.18%26.14%35.38%1.3%37.72%8.93%
EPS (Basic)-0.19-0.28-0.28-0.37-0.37-0.36-0.36-0.25-0.26-0.26-0.34-0.43-0.50-0.81-1.40-1.13-0.84-0.76-0.71-1.53
Diluted Shares Outstanding53.38M53.28M51.02M34.69M34.69M34.51M34.36M34.32M25.05M21.17M21.13M19.05M17.92M13.54M9.69M9.65M9.46M9.45M9.45M7.39M
Basic Shares Outstanding53.38M53.28M51.02M34.69M34.69M34.51M34.36M34.32M25.05M21.17M21.13M19.05M17.92M13.54M9.69M9.65M9.46M9.45M9.45M7.39M
Dividend Payout Ratio--------------------